$NUVL ($NUVL) posted quarterly earnings results for Q1 2026 on Thursday, May 7th. The company reported earnings of -$1.39 per share, missing estimates of -$1.34 by $0.05. The company also reported revenue of $0, equaling estimates of $0 by $0.
You can see Quiver Quantitative's $NUVL stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
$NUVL Insider Trading Activity
$NUVL insiders have traded $NUVL stock on the open market 118 times in the past 6 months. Of those trades, 0 have been purchases and 118 have been sales.
Here’s a breakdown of recent trading of $NUVL stock by insiders over the last 6 months:
- JAMES E FLYNN has made 0 purchases and 2 sales selling 742,574 shares for an estimated $70,874,975.
- JAMES RICHARD PORTER (President and CEO) has made 0 purchases and 16 sales selling 87,433 shares for an estimated $8,832,202.
- ALEXANDRA BALCOM (Chief Financial Officer) has made 0 purchases and 27 sales selling 83,220 shares for an estimated $8,368,625.
- DEBORAH ANN MILLER (Chief Legal Officer) has made 0 purchases and 20 sales selling 62,652 shares for an estimated $6,536,802.
- HENRY E. PELISH (Chief Scientific Officer) has made 0 purchases and 15 sales selling 43,357 shares for an estimated $4,267,773.
- DARLENE NOCI (Chief Development Officer) has made 0 purchases and 23 sales selling 37,417 shares for an estimated $3,769,388.
- MATTHEW SHAIR has made 0 purchases and 8 sales selling 7,500 shares for an estimated $820,273.
- CHRISTOPHER DURANT TURNER (Chief Medical Officer) has made 0 purchases and 7 sales selling 7,417 shares for an estimated $721,320.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API.
$NUVL Hedge Fund Activity
We have seen 139 institutional investors add shares of $NUVL stock to their portfolio, and 84 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- VESTAL POINT CAPITAL, LP removed 1,054,000 shares (-95.8%) from their portfolio in Q4 2025, for an estimated $106,021,860
- BELLEVUE GROUP AG added 1,037,468 shares (+inf%) to their portfolio in Q4 2025, for an estimated $104,358,906
- COMMODORE CAPITAL LP removed 850,000 shares (-60.7%) from their portfolio in Q4 2025, for an estimated $85,501,500
- FMR LLC added 839,647 shares (+8.4%) to their portfolio in Q4 2025, for an estimated $84,460,091
- DEERFIELD MANAGEMENT COMPANY, L.P. removed 742,574 shares (-4.1%) from their portfolio in Q4 2025, for an estimated $74,695,518
- ALLIANCEBERNSTEIN L.P. added 735,477 shares (+1471.9%) to their portfolio in Q4 2025, for an estimated $73,981,631
- BLACKROCK, INC. added 719,466 shares (+17.6%) to their portfolio in Q4 2025, for an estimated $72,371,084
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.
$NUVL Analyst Ratings
Wall Street analysts have issued reports on $NUVL in the last several months. We have seen 9 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- JP Morgan issued a "Overweight" rating on 12/19/2025
- Truist Securities issued a "Buy" rating on 11/24/2025
- Baird issued a "Outperform" rating on 11/18/2025
- Guggenheim issued a "Buy" rating on 11/18/2025
- Goldman Sachs issued a "Buy" rating on 11/18/2025
- Stifel issued a "Buy" rating on 11/17/2025
- Leerink Partners issued a "Outperform" rating on 11/17/2025
To track analyst ratings and price targets for $NUVL, check out Quiver Quantitative's $NUVL forecast page.
$NUVL Price Targets
Multiple analysts have issued price targets for $NUVL recently. We have seen 12 analysts offer price targets for $NUVL in the last 6 months, with a median target of $140.0.
Here are some recent targets:
- Swayampakula Ramakanth from HC Wainwright & Co. set a target price of $155.0 on 04/21/2026
- David Nierengarten from Wedbush set a target price of $125.0 on 04/08/2026
- Eva Fortea Verdejo from Wells Fargo set a target price of $116.0 on 03/30/2026
- Josh Schimmer from Cantor Fitzgerald set a target price of $140.0 on 02/27/2026
- Anupam Rama from JP Morgan set a target price of $145.0 on 12/19/2025
- Gregory Renza from Truist Securities set a target price of $140.0 on 11/24/2025
- Colleen Kusy from Baird set a target price of $158.0 on 11/18/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
